ATXI - Avenue Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-70.06K

Cash

8.236M

Avg Qtr Burn

-1.81M

Short % of Float

4.25%

Insider Ownership

15.70%

Institutional Own.

11.94%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
IV Tramadol Details Post operative acute pain , Pain	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AJ201 Details Huntington's disease, Spinal and bulbar muscular atrophy , Spinocerebellar Ataxia	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.